MedTrace Logo

Coroflex ISAR 2000 Extended Registry (ISAR2000 Extended)

NCT02905214 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4369

Last updated 2022-02-08

No results posted yet for this study

Summary

Postmarket surveillance in terms of the safety and efficacy of Sirolimus-eluting Coroflex ISAR Stent for the treatment of "real world" patients with de-novo and restenotic lesions after stand-alone angioplasty in coronary arteries.

Conditions

  • Coronary Artery Disease (CAD)

Interventions

DEVICE

stenting with the Coroflex ISAR sirolimus-eluting stent

coronary stenting

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    collaborator OTHER

  • B. Braun Melsungen AG

    lead INDUSTRY

Principal Investigators

  • Florian Krackhardt, MD · Charité Virchow Unversity Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-12-31
Completion
2021-12-31

Countries

  • Germany
  • Malaysia
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02905214 on ClinicalTrials.gov